These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17679132)

  • 1. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.
    Pradhan AD; Rifai N; Buring JE; Ridker PM
    Am J Med; 2007 Aug; 120(8):720-7. PubMed ID: 17679132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study.
    Tabák AG; Brunner EJ; Lindbohm JV; Singh-Manoux A; Shipley MJ; Sattar N; Kivimäki M
    Circulation; 2022 Sep; 146(13):995-1005. PubMed ID: 36004644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated hemoglobin measurement and prediction of cardiovascular disease.
    ; Di Angelantonio E; Gao P; Khan H; Butterworth AS; Wormser D; Kaptoge S; Kondapally Seshasai SR; Thompson A; Sarwar N; Willeit P; Ridker PM; Barr EL; Khaw KT; Psaty BM; Brenner H; Balkau B; Dekker JM; Lawlor DA; Daimon M; Willeit J; Njølstad I; Nissinen A; Brunner EJ; Kuller LH; Price JF; Sundström J; Knuiman MW; Feskens EJ; Verschuren WM; Wald N; Bakker SJ; Whincup PH; Ford I; Goldbourt U; Gómez-de-la-Cámara A; Gallacher J; Simons LA; Rosengren A; Sutherland SE; Björkelund C; Blazer DG; Wassertheil-Smoller S; Onat A; Marín Ibañez A; Casiglia E; Jukema JW; Simpson LM; Giampaoli S; Nordestgaard BG; Selmer R; Wennberg P; Kauhanen J; Salonen JT; Dankner R; Barrett-Connor E; Kavousi M; Gudnason V; Evans D; Wallace RB; Cushman M; D'Agostino RB; Umans JG; Kiyohara Y; Nakagawa H; Sato S; Gillum RF; Folsom AR; van der Schouw YT; Moons KG; Griffin SJ; Sattar N; Wareham NJ; Selvin E; Thompson SG; Danesh J
    JAMA; 2014 Mar; 311(12):1225-33. PubMed ID: 24668104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women.
    Pai JK; Cahill LE; Hu FB; Rexrode KM; Manson JE; Rimm EB
    J Am Heart Assoc; 2013 Mar; 2(2):e000077. PubMed ID: 23537807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
    Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N
    Ann Intern Med; 2004 Sep; 141(6):413-20. PubMed ID: 15381514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glycated hemoglobin A
    Sinning C; Makarova N; Völzke H; Schnabel RB; Ojeda F; Dörr M; Felix SB; Koenig W; Peters A; Rathmann W; Schöttker B; Brenner H; Veronesi G; Cesana G; Brambilla P; Palosaari T; Kuulasmaa K; Njølstad I; Mathiesen EB; Wilsgaard T; Blankenberg S; Söderberg S; Ferrario MM; Thorand B
    Cardiovasc Diabetol; 2021 Nov; 20(1):223. PubMed ID: 34781939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
    Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin A1c level and future cardiovascular events among women.
    Blake GJ; Pradhan AD; Manson JE; Williams GR; Buring J; Ridker PM; Glynn RJ
    Arch Intern Med; 2004 Apr; 164(7):757-61. PubMed ID: 15078645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA
    Metcalf PA; Kyle C; Kenealy T; Jackson RT
    J Diabetes Complications; 2017 May; 31(5):814-823. PubMed ID: 28319002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study.
    Rebnord EW; Pedersen ER; Strand E; Svingen GF; Meyer K; Schartum-Hansen H; Løland KH; Seifert R; Ueland PM; Nilsen DW; Nordrehaug JE; Nygård O
    Atherosclerosis; 2015 May; 240(1):115-20. PubMed ID: 25770690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
    Hsu CP; Hsu PF; Chung MY; Lin SJ; Lu TM
    Cardiovasc Diabetol; 2014 Dec; 13():156. PubMed ID: 25467091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visit-to-Visit Variability of Hemoglobin A
    Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
    Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting.
    Nyström T; Holzmann MJ; Eliasson B; Kuhl J; Sartipy U
    J Am Coll Cardiol; 2015 Aug; 66(5):535-43. PubMed ID: 26227192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.